Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

ClinicalTrials.gov ID: NCT06516952

Public ClinicalTrials.gov record NCT06516952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 1:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Study identification

NCT ID
NCT06516952
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
349 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 9, 2024
Primary completion
Oct 18, 2026
Completion
May 2, 2027
Last update posted
May 27, 2026

2024 – 2027

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Cahaba Dermatology Birmingham Alabama 35244
Banner - University Medicine Multispecialty Services Clinic Tucson Arizona 85718
Premier Dermatology Clinical Trials Institute At Northwest Arkansas Fayetteville Arkansas 72703
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Dermatology Research Associates Los Angeles California 90045
Northridge Northridge California 91325
Rendon Center the Dermatology and Aesthetic Center Boca Raton Florida 33486
Driven Research Llc Coral Gables Florida 33134
University of Miami Miller School of Medicine Miami Florida 33136
Research Institute of the Southeast, Llc West Palm Beach Florida 33401
Illinois Dermatology Institute the Chicago Loop Chicago Illinois 60602
Chicago Cosmetic Surgery and Dermatology Chicago Illinois 60654
Center For Medical Dermatology and Immunology Research Chicago Illinois 60657
Northshore University Healthsystem Skokie Illinois 60077
Dermatology Specialists Research Indiana Clarksville Indiana 47129
Oakland Hills Dermatology Auburn Hills Michigan 48326
Hamzavi Dermatology Fort Gratiot Michigan 48059
Somerset Skin Centre Troy Michigan 48084
Medisearch Clinical Trials Saint Joseph Missouri 64506
Washington University School of Medicine St Louis Missouri 63110
The University of New Mexico Unm Health Sciences Center Hsc Albuquerque New Mexico 87131
Montefiore Medical Center East Syracuse New York 13057
Skin Center Dermatology Group New York New York 10956
Stony Brook Dermatology Associates Stony Brook New York 11790
Centricity Research Columbus Columbus Ohio 43213
Wright State Physicians Health Center Dayton Ohio 45324
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130
Dermatology Treatment and Research Center Dallas Texas 75230
Sweetwater Dermatology Sugar Land Texas 77479
Center For Clinical Studies Webster Texas 77598
Frontier Dermatology Mill Creek Washington 98012

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06516952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06516952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →